The Attendance Position 43 of 90

Novo Nordisk A/S FC

116 tickets sold. 5 fans showed up.

Home ground of NVOc holders on Base. NVOc is a stock token that tracks the share price of Novo Nordisk A/S. Counted 21 Nov 2026, 20:34 UTC.

Loading the seat list…

Read-only. Nothing to connect or sign: seats come from public Base data.

Through the turnstiles

Of 116 wallets with a balance, 5 pass every test for a real fan. That is an attendance of 4.3%.

Buyers, last 7 days
2

1 bought for the first time.

Median weekly buy
$38.20

Per wallet, bots removed.

Held by the top 10
100%

17% once pools are left out.

Token price
$37.84

DEX price used for the $10 line.

Tickets sold at Novo Nordisk A/S FC, by kind of holder
TurnstileSeatsShare
Real fansHold $10 or more, bought it themselves, and are a person’s wallet.54.3%
DustHold less than $10. Mostly leftovers worth cents.7463.8%
Farmer-onlyOnly ever received tokens from a giveaway contract. Never bought.00.0%
ContractsPools, vaults and routers. Code, not people.3731.9%
Tickets sold116100%

The front row

The ten fans who have held NVOc longest without selling out. Rank one sits pitchside on the halfway line. How much they hold plays no part.

Addresses are public blockchain records. Tap one to see its ticket.

How this ground is laid out

Novo Nordisk A/S FC has 116 seats in 1 row. A club’s ground is built to hold exactly its holders, so a small club has a small ground.

  • Best seats to the longest holders

    Fans are seated in order of unbroken days held, then by who bought first. The lower rows near halfway fill first and the crowd thins toward the back.

  • Ghosts get what is left

    Dust, farmer-only wallets and contracts take the remaining seats. They are drawn faint, because nobody is sitting there.

  • The crowd wears the kit

    Lit seats take the club’s two colours in its kit pattern, so a full ground would show the whole design. The gaps are the story.

Other grounds

“Novo Nordisk A/S FC” is a nickname for the holders of NVOc. Tropa Club is not affiliated with Novo Nordisk A/S. Holding NVOc is not owning the share. Past performance · not advice.